Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study

被引:0
|
作者
FA Shepherd
MR Johnston
D Payne
R Burkes
J Deslauriers
Y Cormier
LD de Bedoya
J Ottaway
K James
B Zee
机构
[1] Interdepartmental Division of Oncology of the University of Toronto,
来源
British Journal of Cancer | 1998年 / 78卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Thirty-one patients with stage IIIA (N2) non-small-cell lung cancer were randomized to receive radiotherapy alone or chemotherapy with cisplatin and vinblastine followed by surgery. Response rates to induction chemotherapy and radiotherapy were 50% and 53.3% respectively. Complete surgical resection was possible for 62.5% of patients. Median survival times were 16.2 and 18.7 months for radiotherapy alone and chemotherapy-surgery respectively (P = Ns), with no long-term improvement in survival seen with combined-modality treatment.
引用
收藏
页码:683 / 685
页数:2
相关论文
共 50 条
  • [41] Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer
    Mayne, Nicholas R.
    Lin, Belle K.
    Darling, Alice J.
    Raman, Vignesh
    Patel, Deven C.
    Liou, Douglas Z.
    D'Amico, Thomas A.
    Yang, Chi-Fu Jeffrey
    ANNALS OF SURGERY, 2020, 272 (06) : 925 - 929
  • [42] Multicenter study on radiochemotherapy with paclitaxel in non-small-cell lung cancer - Induction chemotherapy followed by radiotherapy versus radiochemotherapy
    Willner, J
    Huber, RM
    Schmidt, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 19 - 19
  • [43] Retrospective cohort study of unresectable stage III non-small-cell lung cancer in Canada
    Seung, S. J.
    Hurry, M.
    Walton, R. N.
    Evans, W. K.
    CURRENT ONCOLOGY, 2020, 27 (04) : E354 - E360
  • [44] Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer
    Hoyer, Morten
    Roed, Henrik
    Hansen, Anders Traberg
    Ohlhuis, Lars
    Petersen, Jorgen
    Nellemann, Hanne
    Berthelsen, Anne Kiil
    Grau, Cai
    Engelholm, Svend Aage
    Von Der Maase, Hans
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (04): : S128 - S135
  • [45] Preresectional chemotherapy in stage IIIA non-small-cell lung cancer:: a 7-year assessment of a randomized controlled trial
    Rosell, R
    Gómez-Codina, J
    Camps, C
    Sánchez, JJ
    Maestre, J
    Padilla, J
    Cantó, A
    Abad, A
    Roig, J
    LUNG CANCER, 1999, 26 (01) : 7 - 14
  • [46] Venous Thromboembolism and Nonsmall Cell Lung Cancer A Pooled Analysis of National Cancer Institute of Canada Clinical Trials Group Trials
    Hicks, Lisa K.
    Cheung, Matthew C.
    Ding, Keyue
    Hasan, Baktiar
    Seymour, Lesley
    Le Maitre, Aurelie
    Leighl, Natasha B.
    Shepherd, Frances A.
    CANCER, 2009, 115 (23) : 5516 - 5525
  • [47] Surgery in stage III non-small-cell lung cancer
    Eberhardt, Wilfried E. E.
    Stamatis, Georgios
    Stuschke, Martin
    LANCET, 2009, 374 (9687): : 359 - 360
  • [48] Stage IIIA category of non-small-cell lung cancer: A new proposal
    Grunenwald, D
    LeChevalier, T
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (01) : 88 - 89
  • [49] Neoadjuvant multimodal treatment of stage IIIA non-small-cell lung cancer
    Thomas, M
    Rube, C
    Semik, M
    Junker, K
    vonEiff, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (33) : 993 - 998
  • [50] Quality-Adjusted Time Without Symptoms or Toxicity Analysis of Adjuvant Chemotherapy in Non-Small-Cell Lung Cancer: An Analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial
    Jang, Raymond W.
    Le Maitre, Aurelie
    Ding, Keyue
    Winton, Tim
    Bezjak, Andrea
    Seymour, Lesley
    Shepherd, Frances A.
    Leighl, Natasha B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4268 - 4273